Published in Pediatr Nephrol on February 01, 1998
Elevated frequency and allelic heterogeneity of congenital nephrotic syndrome, Finnish type, in the old order Mennonites. Am J Hum Genet (1999) 1.25
Congenital nephrotic syndrome responsive to angiotensin-converting enzyme inhibition. Pediatr Nephrol (2005) 0.94
Management of congenital nephrotic syndrome. Pediatr Nephrol (2003) 0.88
Congenital nephrotic syndrome with prolonged renal survival without renal replacement therapy. Pediatr Nephrol (2013) 0.87
Congenital nephrotic syndrome responsive to captopril and indometacin. Arch Dis Child (1999) 0.82
Long-term outcome of heavy proteinuria in patients under 2 years of age. Pediatr Nephrol (2003) 0.81
Glomerular structural factors in progression of congenital nephrotic syndrome. Pediatr Nephrol (2003) 0.80
Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol (2006) 0.79
Neonatal nephrotic presentation of a child with heterozygous NPHS1 mutation. Pediatr Nephrol (2006) 0.75
Cardiac findings in congenital nephrotic syndrome. J Cardiovasc Thorac Res (2011) 0.75
A case of atypical congenital nephrotic syndrome. Pediatr Nephrol (2004) 0.75
NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet (2000) 7.98
A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet (1998) 3.24
Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet (2001) 2.87
X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol (2000) 2.71
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56
Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet (1994) 2.12
Performance of different PEEP valves and helmet outlets at increasing gas flow rates: a bench top study. Minerva Anestesiol (2012) 1.99
Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter. EMBO J (2001) 1.83
Hypomorphic mutations in meckelin (MKS3/TMEM67) cause nephronophthisis with liver fibrosis (NPHP11). J Med Genet (2009) 1.82
Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. Science (1993) 1.77
Characterization of the NPHP1 locus: mutational mechanism involved in deletions in familial juvenile nephronophthisis. Am J Hum Genet (2000) 1.73
Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int (1998) 1.66
A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage. C R Acad Sci III (1991) 1.56
Persistent tubular resistance to aldosterone in infants with congenital hydronephrosis corrected neonatally. J Pediatr (1987) 1.51
Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol (2000) 1.47
Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J Am Soc Nephrol (2001) 1.46
Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. Hum Mol Genet (1999) 1.45
A novel gene that encodes a protein with a putative src homology 3 domain is a candidate gene for familial juvenile nephronophthisis. Hum Mol Genet (1997) 1.44
Mutational analysis of the RPGRIP1L gene in patients with Joubert syndrome and nephronophthisis. Kidney Int (2007) 1.43
Large homozygous deletions of the 2q13 region are a major cause of juvenile nephronophthisis. Hum Mol Genet (1996) 1.42
Immunity to diphtheria and tetanus in a young population on a dialysis regimen or with a renal transplant. J Pediatr (1997) 1.41
Severe hepatorenal failure in a child receiving carbamazepine and erythromycin. Eur J Pediatr (1992) 1.38
Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys. Am J Pathol (2000) 1.37
The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif. J Biol Chem (2001) 1.33
Comprehensive genomic analysis of PKHD1 mutations in ARPKD cohorts. J Med Genet (2005) 1.32
Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay. Am J Hum Genet (1999) 1.28
Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum Mol Genet (1995) 1.28
Acute pyelonephritis as a cause of hyponatremia/hyperkalemia in young infants with urinary tract malformations. Pediatr Infect Dis J (1995) 1.22
Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet (1996) 1.20
Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int (1995) 1.16
Congenital nephrotic syndrome of the Finnish type: linkage to the locus in a non-Finnish population. Pediatr Nephrol (1996) 1.14
Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet (1998) 1.13
PAX2 mutations in renal-coloboma syndrome: mutational hotspot and germline mosaicism. Eur J Hum Genet (2000) 1.10
Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome. Am J Hum Genet (1998) 1.09
Comparison of the concentrations of ceftazidime in the serum of newborn infants after intravenous and intramuscular administration. Antimicrob Agents Chemother (1983) 1.09
Mild fetal hydronephrosis indicating vesicoureteric reflux. Arch Dis Child Fetal Neonatal Ed (1994) 1.08
Mapping a gene (SRN1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. Hum Mol Genet (1995) 1.07
Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol (1998) 1.06
Substitution of arginine for glycine 325 in the collagen alpha 5 (IV) chain associated with X-linked Alport syndrome: characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments. Am J Hum Genet (1992) 1.03
Gentamicin dosage in preterm and term neonates. Arch Dis Child (1977) 1.02
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients. Genes Immun (2010) 1.01
Genetic, clinical, and morphologic heterogeneity in Alport's syndrome. Adv Nephrol Necker Hosp (1993) 1.01
Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis. J Pediatr (1983) 1.00
Evaluation by double-blind placebo-controlled oral challenge of the clinical relevance of IgE antibodies against plant glycans. Allergy (2008) 1.00
Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int (2000) 1.00
Ototoxicity of aminoglycoside antibiotics in infants and children. Pediatr Infect Dis (1983) 1.00
Interleukin 6 activity in infants and children with bacterial meningitis. The Collaborative Study on Meningitis. Pediatr Infect Dis J (1991) 0.98
Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases. Clin Genet (2013) 0.98
Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs. Gene Ther (1999) 0.97
Diffuse leiomyomatosis associated with X-linked Alport syndrome: extracellular matrix study using immunohistochemistry and in situ hybridization. Lab Invest (1997) 0.97
Glomerular lesions in the transplanted kidney in children. Am J Kidney Dis (1987) 0.96
Isolation of kidney complementary DNAs down-expressed in Wilms' tumor by a subtractive hybridization approach. Cancer Res (1993) 0.96
Mapping of a gene for familial juvenile nephronophthisis: refining the map and defining flanking markers on chromosome 2. APN Study Group. Am J Hum Genet (1993) 0.95
Comparative pharmacokinetics of aminoglycoside antibiotics in guinea pigs. Antimicrob Agents Chemother (1982) 0.95
Counterimmunoelectrophoresis and latex particle agglutination in the etiologic diagnosis of presumed bacterial pneumonia in pediatric patients. Pediatr Infect Dis J (1988) 0.94
Severe nephropathy in three adolescents with cystic fibrosis. Arch Dis Child (1991) 0.93
Subtotal but not unilateral nephrectomy induces hyperplasia and protooncogene expression. Am J Physiol (1995) 0.92
Haemolytic uraemic syndrome: therapeutic effect of plasma infusion. Br Med J (Clin Res Ed) (1982) 0.92
Preimplantation genetic diagnosis for autosomal recessive polycystic kidney disease. Reprod Biomed Online (2008) 0.92
Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther (2000) 0.92
A novel renal carbonic anhydrase type III plays a role in proximal tubule dysfunction. Kidney Int (2008) 0.90
Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickel-specific T cell responses. Evidence for the presence of effector CD8+ and regulatory CD4+ T cells. J Invest Dermatol (1998) 0.90
Winter to spring variations of chromophoric dissolved organic matter in a temperate estuary (Po River, northern Adriatic Sea). Mar Environ Res (2010) 0.90
High-resolution mapping of the gene for cystinosis, using combined biochemical and linkage analysis. Am J Hum Genet (1996) 0.90
A missense mutation in podocin leads to early and severe renal disease in mice. Kidney Int (2008) 0.89
Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. II. Ventricular csf concentrations in acute brain post-traumatic syndromes. Eur Neurol (1975) 0.89
Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol (1997) 0.89
Congenital renal damage associated with primary vesicoureteral reflux detected prenatally in male infants. J Pediatr (1994) 0.89
Pharmacokinetics and drug distribution during postnatal development. Pharmacol Ther (1982) 0.89
Deletion of the donor splice site of intron 4 in the glucokinase gene causes maturity-onset diabetes of the young. J Clin Invest (1993) 0.89
[Congenital or childhood nephrotic syndrome with diffuse mesangial sclerosis]. Ann Pediatr (Paris) (1990) 0.88
Characterization of a putative founder mutation that accounts for the high incidence of cystinosis in Brittany. J Am Soc Nephrol (2001) 0.88
Bacterial infections and inflammation in the lungs of cystic fibrosis patients. Pediatr Infect Dis J (2001) 0.88
Influence of intrauterine maturation on the pharmacokinetics of amikacin in the neonatal period. Pediatr Res (1982) 0.87
Refined mapping of a gene (NPH1) causing familial juvenile nephronophthisis and evidence for genetic heterogeneity. Genomics (1994) 0.86
Diffuse mesangial sclerosis: a congenital glomerulopathy with nephrotic syndrome. Adv Nephrol Necker Hosp (1993) 0.86
Renal tubular acidosis in a case of Shwachman's syndrome. Acta Paediatr Scand (1986) 0.86
Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define the DL critical region. Cytogenet Cell Genet (1997) 0.86
Deletion spanning the 5' ends of both the COL4A5 and COL4A6 genes in a patient with Alport's syndrome and leiomyomatosis. Hum Mutat (1994) 0.86
A mouse model suggests two mechanisms for thyroid alterations in infantile cystinosis: decreased thyroglobulin synthesis due to endoplasmic reticulum stress/unfolded protein response and impaired lysosomal processing. Endocrinology (2015) 0.86
Clinical pharmacology of ceftazidime in paediatrics. J Antimicrob Chemother (1983) 0.85
Increased sodium requirement following early postnatal surgical correction of congenital uropathies in infants. Pediatr Nephrol (1990) 0.85
IL-8 and pH values in exhaled condensate after antibiotics in cystic fibrosis children. Int J Immunopathol Pharmacol (2007) 0.85
N-acetyl-beta-D-glucosaminidase (NAG) levels in amniotic fluid or urine in prenatal and postnatal life. Early Hum Dev (1986) 0.84
Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Italian Sentinel Group on Pediatric Infectious Diseases. Pediatr Infect Dis J (1999) 0.84
Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome. Am J Med Genet (1995) 0.84
Somatic deletion of the 5' ends of both the COL4A5 and COL4A6 genes in a sporadic leiomyoma of the esophagus. Am J Pathol (1998) 0.84
[Pigmentosum retinis and tubulo-interstitial nephronophtisis in Sensenbrenner syndrome: a case report]. J Fr Ophtalmol (2000) 0.83
Ceftazidime in the treatment of pediatric patients with severe urinary tract infections due to Pseudomonas spp. Antimicrob Agents Chemother (1984) 0.83
A specific glomerular lesion of the graft: allograft glomerulopathy. Kidney Int Suppl (1993) 0.83
Medullary cystic kidney disease with hyperuricemia and gout in a large Cypriot family: no allelism with nephronophthisis type 1. Am J Med Genet (1998) 0.83
Diffuse esophageal leiomyomatosis with perirectal involvement mimicking Hirschsprung disease. Gastroenterology (2001) 0.83
[Cerebellar vermis hypoplasia with extracerebral involvement (retina, kidney, liver): difficult to classify syndromes]. Arch Pediatr (2001) 0.82
Identification and characterisation of the murine homologue of the gene responsible for cystinosis, Ctns. BMC Genomics (2000) 0.82
A pilot survey of cystic fibrosis clinical manifestations in CFTR mutation heterozygotes. Genet Test (2001) 0.82
Benign familial hematuria associated with a novel COL4A4 mutation. Pediatr Nephrol (2001) 0.82
Macromolecular IgA and abnormal IgA reactivity in sera from children with IgA nephropathy. Italian Collaborative Paediatric IgA Nephropathy Study. Clin Nephrol (1995) 0.82
Chemical and biological properties of a phenol-water extract from Leptospira interrogans. Evidence for the absence of lipopolysaccharide. Infection (1988) 0.81
Methodological and clinical aspects of urinary N-acetyl-glucosaminidase in pediatric subjects. Biochem Med (1981) 0.81
Effect on nephrotic syndrome on absorption and disposition of prednisolone in children. Int J Pediatr Nephrol (1982) 0.81